Advanced Chemotherapy Technologies
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2301 Stonehenge Dr Ste 204, Raleigh, Nor...Phone Number
(919) 917-7944Website
www.advancedchemotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Advanced Chemotherapy Technologies
Founded in 2014, Advanced Chemotherapy Technologies is a privately owned, clinical-stage company developing novel approaches to local drug delivery. Its lead product is the first-in-class to combine iontophoresis drug delivery with an implantable delivery system to target drug delivery with laser-like precision. Advanced Chemotherapy Technologies drug delivery technology was first developed at and licensed from the University of North Carolina at Chapel Hill in conjunction with UNC Lineberger Comprehensive Cancer Center. The company is headquartered in Raleigh, North Carolina.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Advanced Chemotherapy Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Advanced Chemotherapy Technologies recently announced quarterly report
Product Launch: Get notified when Advanced Chemotherapy Technologies launches new products
Funding: Get notified immidiatlly once Advanced Chemotherapy Technologies has new funding data
Check if Advanced Chemotherapy Technologies has recently received funding, and reach out quickly before it becomes old news!
Advanced Chemotherapy Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Advanced Chemotherapy Technologies had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Advanced Chemotherapy Technologies
Website visits: Recent activity has been detected on your website
Check out if Advanced Chemotherapy Technologies is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Advanced Chemotherapy Technologies as Masked Content
Find more new buyers
Compare Similar Companies to Advanced Chemotherapy Technologies
Compare insights from companies similar to Advanced Chemotherapy Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Advanced Chemotherapy Tec...
<$5M
1-10
Private
<$5M
2014
N/A
Company Profile Activity
Activity Insights
Advanced Chemotherapy Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Advanced Chemotherapy Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Advanced Chemotherapy Technologies.
Advanced Chemotherapy Technologies financials insights
Gather financial insights about Advanced Chemotherapy Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$2.5M
Advanced Chemotherapy Technologies Tech Stack
A closer look at the technologies used by Advanced Chemotherapy Technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves
Lateral Move
Executive Move
Executive Moves
Funding
Funding
Advanced Chemotherapy Technologies News & Media
Advanced Chemotherapy Technologies, Inc. Awarded $4 Million NIH Grant to Pursue Treatment for Locally Advanced Non-resectable Pancreatic Cancer
RALEIGH, N.C.--(BUSINESS WIRE)--ACT announced today that it has been awarded a Phase IIb SBIR grant expected to total $4 million over two years from the National Cancer Institute.Advanced Chemotherapy Technologies, Inc. Announces $2.5M Series A Investment by Spectrum Financial
RALEIGH, N.C.--(BUSINESS WIRE)--Advanced Chemotherapy Technologies, a clinical stage oncology drug delivery company, closes its Series A financing.Advanced Chemotherapy Technologies, Inc. Announces $5.5M Series A Financing Round led by Khosla Ventures
RALEIGH, N.C.--(BUSINESS WIRE)--Advanced Chemotherapy Technologies, Inc. Announces $5.5M Series A Financing Round led by Khosla Ventures
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Advanced Chemotherapy Technologies
Sign Up For FreeTo access detailed company insights
Founded in 2014, Advanced Chemotherapy Technologies is a privately owned, clinical-stage company developing novel approaches to local drug delivery. Its lead product is the first-in-class to combine iontophoresis drug delivery with an implantable delivery system to target drug delivery with laser-like precision. Advanced Chemotherapy Technologies d... Read More
